MedPath

EFFECT OF GUDUCHYADICHURNA AND ELADICHURNA IN AMLAPITTA(HYPERACIDITY)

Recruiting
Conditions
PATIENT SUFFERING FROM AMLAPITTA.
Registration Number
CTRI/2017/05/008719
Lead Sponsor
GOVT AKHANDANAND AYURVED COLLEGE
Brief Summary

**This study is a randomised, participants blinded, parallel group, active controlled trial to evaluate the efficacy of *Guduchyadi Churna in a*Dose of  10gm/day two divided dose with water Duration: 4 weeks in 15 patients with GROUP A and also  to evaluate the efficacy of  *Eladi Churna in a*Dose of  10gm/day two divided dose with water Duration: 4 weeks in 15 patients of GROUP B in Amlapitta.**

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with classical signs & symptoms of Amlapitta.Avipaka (Indigestion), Klama(Lassitude), Utklesha (Nausea), Tiktodgara(Bitter eruction), Amlodgara(sour eruction),Gaurav(heaviness of body),Hrit Daha(Heart buru), Kantha Daha (Burning in throat), Aruchi (Anorexia).

Exclusion Criteria
  • Patients suffering from Hematemesis, Acute diarrhoea, Intestinal T.B, Gastric and Peptic ulcer, uncontrolled D.M. and HTN, Arsha, Carcinoma, cardiac disorders etc.
  • serious condition of the patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Result will be assessed on the basis of relief in the Signs and symptoms of Amlapitta4 WEEKS
Secondary Outcome Measures
NameTimeMethod
Result will be assessed on the basis of relief in the Signs and symptoms of Amlapitta4 weeks

Trial Locations

Locations (1)

AKHANDANAND AYURVED COLLEGE

🇮🇳

Ahmadabad, GUJARAT, India

AKHANDANAND AYURVED COLLEGE
🇮🇳Ahmadabad, GUJARAT, India
DR MOHIT PAGHDAR
Principal investigator
8866608559
dr.mppaghdar273@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.